Search This Blog

Wednesday, February 4, 2026

Evogene unit Biomica grants Shanghai Lishan Biopharm exclusive world license for oncology candidate

 BMC128, with Biomica eligible for development milestones and sales royalties

https://finviz.com/quote.ashx?t=EVGN&p=d

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)